These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 593610)

  • 41. [2 cases of anti-Kell antibody detection].
    Bashlaĭ AG; Kissel'gof AM
    Probl Gematol Pereliv Krovi; 1966 May; 11(5):58-60. PubMed ID: 5993247
    [No Abstract]   [Full Text] [Related]  

  • 42. [Incidence of erythroblastosis in the umbilical cord blood of newborn infants with materno-fetal Rh factor incompatibility without signs of isoimmunization].
    Moscatelli P; Pantarotto F; Melevendi C
    Minerva Pediatr; 1967 Oct; 19(43):1901-2. PubMed ID: 4974603
    [No Abstract]   [Full Text] [Related]  

  • 43. [Prevention and treatment of Rh. isoimmunization. Results].
    Martínez M; Lozano G; Flores F; Fernández P; Garrido G
    Acta Obstet Ginecol Hisp Lusit; 1971 Mar; 19(2):149-57. PubMed ID: 4996734
    [No Abstract]   [Full Text] [Related]  

  • 44. [Treatment of the fetus with Rh incompatibility by the combined methods of plasmapheresis and intrauterine blood transfusion].
    Lozińska D; Radomska I; Samborska K; Dmoch E; Garwoliński J; Lenkiewicz B; Góralski T
    Pol Tyg Lek; 1988 Nov; 43(45):1449-51. PubMed ID: 3151013
    [No Abstract]   [Full Text] [Related]  

  • 45. Exchange transfusions and top-up transfusions in neonates with Kell haemolytic disease compared to Rh D haemolytic disease.
    Rath ME; Smits-Wintjens VE; Lindenburg IT; Brand A; van Kamp IL; Oepkes D; Walther FJ; Lopriore E
    Vox Sang; 2011 Apr; 100(3):312-6. PubMed ID: 20849463
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Early determination of ABO incompatibility. Catamnestic studies of 141 pregnancies with suspicion or clinical evidence of ABO incompatibility].
    Kröger E; Scherbening G
    Munch Med Wochenschr; 1969 Nov; 111(46):2388-92. PubMed ID: 5394823
    [No Abstract]   [Full Text] [Related]  

  • 47. [Several problems of pregnancy complicated by blood group incompatibility].
    Noda K
    Nihon Hoigaku Zasshi; 1968 Jul; 22(4):339-50. PubMed ID: 4973992
    [No Abstract]   [Full Text] [Related]  

  • 48. [Icterus gravis and exchange transfusion].
    Tulzer W; Griebler T
    Wien Med Wochenschr; 1967 Apr; 117(13):334-7. PubMed ID: 4968441
    [No Abstract]   [Full Text] [Related]  

  • 49. [Immunologic and pathogenic problems posed by hemolytic diseases caused by Rhesus incompatibility of the firstborn infant].
    Gabriel H
    J Gynecol Obstet Biol Reprod (Paris); 1972; 1(5 Suppl 2):231-2. PubMed ID: 4220063
    [No Abstract]   [Full Text] [Related]  

  • 50. Erythroblastosis fetalis with hydrops resulting from anti-Kell isoimmune disease.
    Frigoletto FD; Davies IJ
    Am J Obstet Gynecol; 1977 Apr; 127(8):887. PubMed ID: 851149
    [No Abstract]   [Full Text] [Related]  

  • 51. [Hemolytic disease of the newborn caused by rare incompatibility in the Rhesus system].
    Perrimond H; Battaglini P; Melis C; Sebag F; Chauvin C; Orsini A
    Mars Med; 1972; 109(4):275-8. PubMed ID: 5070402
    [No Abstract]   [Full Text] [Related]  

  • 52. Hemolytic disease of the newborn due to anti-Jsb.
    Purohit DM; Taylor HL; Spivey MA
    Am J Obstet Gynecol; 1978 Aug; 131(7):755-6. PubMed ID: 686069
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Hemolytic disease of the newborn infant caused by the Kidd-system blood incompatibility].
    Dzierzkowa-Borodej W; Maszkiewicz W; Wiewiórowska E
    Pediatr Pol; 1977 Feb; 52(2):215-6. PubMed ID: 557194
    [No Abstract]   [Full Text] [Related]  

  • 54. [A few remarks of the immunohematologist in connection with administration of exchange transfusions in the newborn with hemolytic disease (with respect to the transfusion material)].
    Kulich V; Sauer J
    Cesk Gynekol; 1969 Oct; 34(8):488-90. PubMed ID: 5354332
    [No Abstract]   [Full Text] [Related]  

  • 55. [Hemolytic disease of the newborn in first-born infants. (Clinical contribution)].
    Baratta A; Torsiglieri W
    Quad Clin Ostet Ginecol; 1966 Sep; 21(9):587-94. PubMed ID: 5993026
    [No Abstract]   [Full Text] [Related]  

  • 56. [Materno-fetal Rh-factor isoimmunization without hemolytic disease].
    Di Palma L; Carcano G; Manzi F
    Pediatria (Napoli); 1975 Jun; 83(2):317-25. PubMed ID: 809742
    [No Abstract]   [Full Text] [Related]  

  • 57. [Consideration of 116 pregnancies with feto-maternal immunization. (Maternité de Pellegrin, 19571964)].
    Mahon R; Pery G; Soumireu-Mourat J; Van Oort JL
    Rev Fr Gynecol Obstet; 1966 Oct; 61(10):685-700. PubMed ID: 5983668
    [No Abstract]   [Full Text] [Related]  

  • 58. Blood transfusion: the hidden dangers.
    Anderson T
    Pract Midwife; 2004 Mar; 7(3):12-6. PubMed ID: 15058056
    [No Abstract]   [Full Text] [Related]  

  • 59. [Anti-D isoimmunization: cases at the L. Mangiagalli Obstetrical and Gynecological Clinic I from June 1974 to December 1978. Perinatal results].
    Brambati B; Zuliani G; Regalia AL; Pardi G; Chierichetti G; Dambrosio F; Caccamo ML
    Ann Ostet Ginecol Med Perinat; 1980; 101(4):225-34. PubMed ID: 6787970
    [No Abstract]   [Full Text] [Related]  

  • 60. [Hemolytic disease of the newborn due to Kell sensitization].
    Beller U; Hochner-Celnikier D; Ron M; Palti Z; Beyth Y
    Harefuah; 1981 Jul; 101(1-2):14-5. PubMed ID: 7319365
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.